Since 2001, an aid consortium known as Gavi has accounted for over half of vaccination expenditure in the 75 eligible countries with an initial per capita GNI below $1,000. 

Health Aid Eligibility and Country Income Status: A Mismatch Mishap?

Blog Post

Donors give arbitrary income lines a lot of power in determining funding allocation.  This issue is particularly true in the health sector, where organizations like the GAVI Alliance (GAVI) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) determine how much support a country will get based on its income status.  But the income level of a country alone should not make a country ineligible or less eligible for donor funding – especially when estimates of such income levels can change overnight.

GAVI Moves on Better Data Verification

Blog Post

Data quality and rigorous measurement is important for any funder using performance-based or results-based aid. Poorly measured or self-reported data are often subject to major biases.

New Data, Same Story: Disease Still Concentrated in Middle-Income Countries

Blog Post

This is a joint post with Yuna Sakuma.

The majority of the world’s sick live in middle-income countries (MIC) – mainly Pakistan, India, Nigeria, China and Indonesia (or PINCI), according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.  Sound familiar? Andy Sumner, Denizhan Duran, and I came to the same conclusion in a 2011 paper, but we used 2004 disease burden data, which didn’t provide an up-to-date view of reality.  So I was pleased to see that our findings still hold based on IHME’s 2010 Global Burden of Disease (GBD) estimates.  

Meet the Global Health Family: A Cheat Sheet

Blog Post

This is a joint post with Rachel Silverman.

Through our Value for Money working group, we’ve spent much of the past year immersed in the world of global health funding agencies. With so many new agencies, particularly in the last quarter century (Figure 1), understanding the intricacies of the global health family can be daunting, even for the most devoted observers.

World Immunization Week: Leaders and Laggards

Blog Post

Immunization saves millions of lives, is among the most cost-effective health interventions ever developed, and has attracted a great deal of attention and funding from public and private donors in recent years.  Indeed, global health leaders have committed to making this the ‘Decade of Vaccines’ with the vision of delivering universal access to immunization by 2020, and the World Health Organization has put out a Global Vaccine Action Plan (GVAP) to serve as a blueprint to achieving this goal.

Saving Lives by Visualizing Deaths

Blog Post

My recent wonky indulgence has been exploring the visualization tool of the Global Burden of Disease Study (GBD), which produces stunning graphs that display a snapshot of our planet’s disease burden across 5-year intervals from 1990 to 2010. The global and regional results of the study were launched in December 2012 in a special issue of The Lancet, and there are several country-specific papers expected this year.

BMGF’s New President for Global Development: A Bonanza for Global Health?

Blog Post

Chris Elias, President & CEO at PATH, will step down from his current position and join the Bill & Melinda Gates Foundation (BMGF) as President for global DEVELOPMENT in February 2012. Yes, that’s global development, not global health. First reactions from many in global health lamented the "loss" of one of the field’s most accomplished and visible experts. But as we digested the details of the announcement and discussed its implications, we realized that the Foundation’s decision could be a bonanza for global health. Here are two reasons why:

Busan Is in the Air: GAVI Gets in Front

Blog Post

One of the good things about a big international meeting is that agencies become motivated to deliver on commitments made at earlier big international meetings. As aid-world gears up for the OECD aid effectiveness meeting in Busan in November, agencies are checking their compliance with recommendations from earlier meetings, which include improving accountability, defining measures and standards of performance, and monitoring and evaluating implementation (see here).